Development of Cold-adapted Recombinant Live, Attenuated Influenza a Vaccines in the U.s.a. and U.s.s.r

@inproceedings{Kendal2002DevelopmentOC,
  title={Development of Cold-adapted Recombinant Live, Attenuated Influenza a Vaccines in the U.s.a. and U.s.s.r},
  author={Alan P. Kendal and Hunein F. Maassab and Galina I. Alexandrova and Yuri Ghendon},
  year={2002}
}
Influenza remains a major public health problem in many countries. Periodic epidemics disrupt economic and social activities within entire communities, impose sudden large demands on available medical facilities, and can cause excess mortality, particularly in the elderly or those with certain chronic illnesses [5,7,21]. Vaccination can provide significant protection against infection and illness during natural epidemics, but this protection is usually considered to be of limited duration… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 65 references

A study of excess mortality during influenza epidemics in the United States , 1968 - 1976

D. W. Aliing, W. C. Blackwelder, C. H. Stuart-Harris
Am . J . Epidemiol . • 1981

Genetic and biochemical analysis of the A/Ann Arbor/6/60 cold adapted mutant

N. J. Cox, I. Konnecke, A. P. Kendal, H. F. Maassab
ICN-UCLA • 1981

Genetic synergism

N. J. Cox, A. P. Kendal, H. F. Maassab, C. Scholtissek, S. B. Spring
1981

Similar Papers

Loading similar papers…